HOME >> BIOLOGY >> NEWS
Dietary ginger may work against cancer growth

MINNEAPOLIS / ST. PAUL--The substance that gives ginger its flavor appears to inhibit the growth of human colorectal cancer cells, according to research at the University of Minnesota's Hormel Institute in Austin, Minn. Working with mice that lack an immune system, research associate professor Ann Bode and her colleagues found slower rates of cancer growth in mice given thrice-weekly feedings of [6]-gingerol--the main active component of ginger. Bode and co-author Zigang Dong, director of the institute, will discuss the work at a press conference from 9:30 to 10:30 a.m. MST Tuesday, Oct. 28, during a meeting of the American Association for Cancer Research in the J.W. Marriott Desert Resort and Spa in Phoenix. They will also present the work at a poster session from 1 to 2:30 p.m. and from 6 to 7:30 p.m. MST in the Marriott.

"Plants of the ginger family have been credited with therapeutic and preventive powers and have been reported to have anti-cancer activity," said Bode. "The substance called [6]-gingerol is the main active compound in ginger root and the one that gives ginger its distinctive flavor."

The researchers tested [6]-gingerol's powers by feeding a half milligram to 20 mice three times a week before and after injecting human colorectal tumor cells into their flanks. Control mice were treated the same, except their food contained no [6]-gingerol. Tumors were allowed to grow until they reached a size of one cubic centimeter (0.06 cubic inch), after which the mice were euthanized. The mice, known as athymic nude mice, are often used in such studies because they provide a living-body environment in which tumors can grow without interference from an immune system.

The first tumors appeared 15 days after the cells were injected. At that time, 13 tumors of measurable size had appeared among the control mice, four among the [6]-gingerol-treated mice. Mice consuming [6]-gingerol lagged in both the number of animals with measurable tumors
'"/>

Contact: Deane Morrison
morri029@umn.edu
612-624-2346
University of Minnesota
28-Oct-2003


Page: 1 2

Related biology news :

1. Dietary supplement shows promise for improving immune function in the elderly
2. Dietary supplement many not lower prostate cancer risk
3. Dietary component kills bacterial cause of ulcers and stomach cancer
4. Dietary soy reduces pain, inflammation in rats
5. Dietary changes can lower colon cancer risk in families with a history of the disease
6. Dietary supplements make old rats youthful, may help rejuvenate aging humans, according to UC Berkeley study
7. Dietary approaches to stop hypertension diet reduces cholesterol and long-term cardiovascular risk
8. Dietary study finds marijuana users have normal nutritional status, risky lifestyle habits
9. Dietary fibre supplements may be harmful
10. Dietary fat itself not likely to cause breast cancer
11. Dietary patterns predict heart attack risk in middle-aged men

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/10/2019)... ... January 10, 2019 , ... When Dr. James L. Sherley, ... was invited to contribute a chapter to the new book Perinatal Stem Cells: Research ... Asymmetrex’s effort to address a debilitating secret of stem cell medicine. For more ...
(Date:1/7/2019)... ... 07, 2019 , ... Concerto HealthAI, a technology leader in ... oncology and other key therapeutic areas, and its Chief Executive Officer, Dr. Jeff ... spanning the entire healthcare landscape, on January 8, 2019, at 2:30 p.m. in ...
(Date:1/4/2019)... , ... January 03, 2019 , ... Stay on top ... medical device and food industries. Access to all webinars is free, so be sure ... in your field! Visit http://www.xtalks.com to check out our upcoming webinars, or ...
Breaking Biology News(10 mins):
(Date:1/8/2019)... ... January 08, 2019 , ... The American Society of Gene and ... by a selection committee made up of industry leaders identified by the ASGCT board ... are mentored awards created to support ASGCT members designing transformative pilot studies in gene ...
(Date:1/4/2019)... ... January 02, 2019 , ... CellMax Life , a ... blood, has been named as a partner in Medigen Biotech’s upcoming cell therapy ... for cancer treatment, will use CellMax Life’s circulating tumor cell platform CMxTM, in ...
(Date:12/19/2018)... Md. (PRWEB) , ... December 19, 2018 , ... ... for Life Science, announces the validated release of Limfinity® version 7.1. The new ... important technical offering from RURO as 2018 comes to an end. , Validation ...
(Date:12/14/2018)... ... December 14, 2018 , ... ... have been given the green light to immediately begin a clinical patient trial ... The medical devices bureau of Health Canada has granted what is called an ...
Breaking Biology Technology:
Cached News: